
Why Period Pain Isn't ‘Normal'? - Decoding the Endometriosis and Infertility Connection
Meet Priya, a 34-year-old software professional who endured excruciating period pain for years, brushing it off as something normal just another part of being a woman. Like many, she was told to 'tough it out.' It wasn't until the pain began disrupting her daily life that she sought medical help and was diagnosed with endometriosis, a condition that often goes undetected and can quietly impact fertility if not managed in time.
Endometriosis is a medical condition where tissue similar to the lining inside the uterus starts growing outside it usually on the ovaries, fallopian tubes, or other parts of the pelvis. This tissue behaves like the uterine lining: it thickens, breaks down, and bleeds each month. But unlike a normal period, this blood has nowhere to go.
Over time, this can cause pain, swelling, scar tissue, and in some cases, fertility issues. The most common sign is severe period pain, but it can also lead to discomfort during sex, heavy bleeding, and fatigue. As per World Health Organization (WHO) states that endometriosis may affect 10% of women of reproductive age globally, many of whom may be undiagnosed for years. While not every woman with endometriosis has fertility issues, studies indicate that endometriosis is associated with infertility in 30–50% of cases (American Society for Reproductive Medicine). In some cases, even when a woman with endometriosis is fertile, the pain and hormonal imbalances can interfere with her ability to conceive naturally.
Data Point Statistic Source Global prevalence among women of reproductive age ~10% (approx. 190 million globally) World Health Organization (WHO), 2023 Average delay in diagnosis 7 to 10 years Human Reproduction Update, Volume 27, Issue 5, 2021 Percentage of women with endometriosis who face infertility 30% to 50% American Society for Reproductive Medicine (ASRM) Percentage of infertile women found to have endometriosis 25% to 50% Journal of Endometriosis and Pelvic Pain Disorders, ScienceDirect Women reporting moderate to severe menstrual pain Around 60% of endometriosis patients Journal of Endometriosis, Vol. 2, Issue 2 Average time to treatment after first symptoms Often more than 6 years BMJ Open, 2019
Endometriosis is one of the most underdiagnosed reproductive health disorders, often taking years to be identified. On average, there is a delay of 7 to 10 years between the onset of symptoms and a proper diagnosis (Source: Human Reproduction Update). This delay happens for several key reasons: Symptom Overlap : The pelvic pain, heavy bleeding, and digestive discomfort caused by endometriosis often mimic other conditions like irritable bowel syndrome (IBS) or regular menstrual cramps, making it difficult to pinpoint.
: The pelvic pain, heavy bleeding, and digestive discomfort caused by endometriosis often mimic other conditions like irritable bowel syndrome (IBS) or regular menstrual cramps, making it difficult to pinpoint. Normalisation of Pain : Many women are led to believe that intense period pain is just part of life. As a result, they delay seeking help until symptoms worsen. Nearly 60% of women with endometriosis experience moderate to severe menstrual pain ( Journal of Endometriosis ).
: Many women are led to believe that intense period pain is just part of life. As a result, they delay seeking help until symptoms worsen. Nearly ( ). Invasive Diagnosis: A confirmed diagnosis usually requires laparoscopic surgery, a procedure that many delay unless symptoms become severe, contributing further to late detection.
Dr. Rashmika Gandhi, Senior Reproductive Health Specialist at Birla Fertility & IVF, explains:
'Because the symptoms of endometriosis are so varied - and often dismissed as 'normal period pain' - many women suffer silently for years. Early and accurate diagnosis is critical, not just for managing pain, but also for addressing potential fertility issues.' Symptoms of Endometriosis
While there is currently no definitive cure for endometriosis, several treatment options can manage its symptoms and potentially reverse its progression: Hormonal Therapies: These therapies aim to shrink endometrial lesions and reduce inflammation. Medications such as birth control pills, GnRH agonists, and progestins can help reduce or eliminate pain by regulating the menstrual cycle.
These therapies aim to shrink endometrial lesions and reduce inflammation. Medications such as birth control pills, GnRH agonists, and progestins can help reduce or eliminate pain by regulating the menstrual cycle. Surgical Intervention: Laparoscopic surgery can remove endometrial implants and adhesions, often leading to significant pain relief and improved fertility outcomes.
Laparoscopic surgery can remove endometrial implants and adhesions, often leading to significant pain relief and improved fertility outcomes. Pain Management: Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed to manage the pain associated with endometriosis.
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed to manage the pain associated with endometriosis. Lifestyle Modifications: Incorporating a balanced diet rich in antioxidants, regular exercise, and stress-reduction techniques like yoga or meditation can help alleviate symptoms.
Incorporating a balanced diet rich in antioxidants, regular exercise, and stress-reduction techniques like yoga or meditation can help alleviate symptoms. Emerging Treatments: Research into novel therapies, such as immunomodulators and targeted anti-inflammatory drugs, offers hope for more effective long-term management.
Dr. Rashmika Gandhiadds, 'While science is yet to find a cure for endometriosis, a combination of surgical and non-surgical treatments tailored to each woman's needs can significantly reduce symptoms and improve quality of life.'
Endometriosis is more than just painful periods; it's a chronic condition that can affect quality of life and fertility if left unmanaged. Recognising symptoms early, understanding potential risks, and seeking timely medical care can make a significant difference.
Open conversations and better awareness help individuals make informed choices about their health. No one should have to live with ongoing pain or unanswered questions about their body.
If you've been experiencing severe menstrual cramps, pelvic pain, or difficulties conceiving, consult a gynaecologist. With the right care and support, managing endometriosis is possible — and so is living well.
Note to readers: This article is part of Mint's paid consumer connect Initiative. Mint assumes no editorial involvement or responsibility for errors, omissions, or content accuracy.
Want to get your story featured as above? click here!
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


India.com
an hour ago
- India.com
COVID-19 Cases In India: Active Cases Rise To 5,364; Delhi 592 - Kerala Leading With 1,679 Cases; 4 Deaths In 24 Hours
COVID 19 Cases Rising In India Live Updates: India is once again witnessing an unsettling rise in COVID-19 cases, with the number of active infections climbing to 5,364; according to the Ministry of Health and Family Welfare's latest update as of 8:00 AM IST, June 7, 2025. Leading the current spike is Kerala, with 192 fresh infections, pushing its active caseload to 1,679; nearly half of the country's total. Meanwhile, West Bengal added 58 new cases, increasing its active tally to 596, while the national capital Delhi, recorded 30 new infections, taking its active cases to 592. Maharashtra, another state that has seen consistent rises in previous waves, reported 22 new COVID-19 cases, bringing the total number of infections recorded to 548, as per the state's public health department. As per May 2025 classifications by the World Health Organization (WHO), subvariants LF.7 and NB.1.8.1 are categorized as Variants Under Monitoring, meaning they are not yet deemed as Variants of Concern or Variants of Interest. However, these strains are suspected to be contributing to the rising infections not just in India but also across China and other parts of Asia. Despite the emergence of new subvariants, the JN.1 strain remains the most dominant, accounting for a staggering 53% of all positive cases across the country. According to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), a case of NB.1.8.1 was detected in Tamil Nadu in April, while four cases of LF.7 were identified in Gujarat earlier this month. With the virus subtly shifting form and symptoms evolving, health authorities are urging the public to maintain precautionary measures, including hygiene, mask use in crowded places, and timely testing. Although hospitalisation remains low, experts warn that complacency could reverse progress. Stay informed, and if you're experiencing mild symptoms like fatigue, a sore throat, or gastrointestinal discomfort, it's best to test early and isolate to prevent further spread. Say Tuned To Zee News For Latest Updates...


Indian Express
3 hours ago
- Indian Express
Measles spike in US shows how vaccine hesitancy threatens decades of public-health progress
Vaccines are critical tools for the containment and elimination of infectious diseases. They work not merely by protecting individuals, but by reducing community transmission. There have been several global pushes to improve vaccine uptake over the years, but one major coordinated effort occurred in 2021 in response to the Covid pandemic, which saw the most rapid vaccine introduction in history. Globally, the years with the most vaccine introductions have typically coincided with public health initiatives, funding boosts, or as a response to pandemics. The 1980s and 1990s saw WHO's Expanded Programme on Immunisation (EPI) with DTP (diphtheria-tetanus-pertussis), polio, measles, BCG (tuberculosis) vaccines and Hepatitis B and Hib vaccines introduced in the late 1990s. The 2000s saw accelerated introductions of Hepatitis B, Haemophilus influenzae type B (Hib), and yellow fever vaccines in low-income countries, marking a shift in global access to routine vaccines. The introduction of new and underused vaccines like pneumococcal conjugate vaccine (PCV), rotavirus vaccine, HPV and Measles-Rubella (MR) vaccine marked the next decade. The United States is currently experiencing a significant resurgence of measles, with 1,046 confirmed cases as of May 27. This marks a sharp increase from previous years, with the majority of cases occurring among unvaccinated individuals in regions with declining immunisation rates. Measles was officially eliminated from the US in 2000. This implies that new cases occur only when someone contracts measles abroad and returns to the country. A new study from Johns Hopkins points out that the significant drop in childhood vaccination rates is concerning because herd immunity requires at least 95 per cent vaccination coverage. The MMR vaccine is probably one of the most effective vaccines. A single dose gives 93 per cent protection from infection, and two doses up to 98 per cent. Measles, which can be deadly for unvaccinated children, is highly contagious. Factors like post-pandemic vaccine hesitancy, non-evidence-based fears of the association between the MMR vaccine and autism, and the complacency of populations who may not remember the long-term sequelae of measles infection are behind the dwindling measles vaccination rates in the US. Measles is often regarded as the 'canary in the coalmine' — if cases spread, it is a warning that other disease outbreaks might spring up where there are gaps in vaccination coverage. Its resurgence in the US is a global warning that even advanced health systems are vulnerable without consistent immunisation. Globally, only 83 per cent of children received the first dose of the measles vaccine in 2023; 74 per cent received the second dose. These figures fall short of the 95 per cent coverage needed to prevent outbreaks. India has made significant strides in its immunisation efforts, particularly under the UIP. India achieved a national immunisation coverage of 93.5 per cent in 2023–24, indicating that the majority of children received all recommended vaccines by the age of two. Since its inception, Mission Indradhanush, focused on areas with low immunisation rates, has completed 12 phases, vaccinating 5.46 crore children and 1.32 crore pregnant women across 554 districts. However, the measles upsurge in the US shows one cannot ignore increasing vaccine hesitancy, particularly since it threatens to throw away the gains made in the containment of infectious diseases. In resource-limited settings, this can lead to healthcare systems being overwhelmed and a general delay in uptake of new vaccines. Misinformation has contributed significantly to the declining uptake for vaccines. The flu vaccination rates among NHS staff in the UK, for instance, dropped to their lowest in nearly 15 years in 2024-25. So far, India has remained immune to vaccine hesitancy. Previous experience with successful vaccination campaigns and government endorsements have played an important role in creating a positive perception of vaccines. However, we must remain alert and actively consider putting in place a multi-pronged, culturally nuanced plan to address vaccine hesitancy. The writer is senior scientist, ICMR


Time of India
7 hours ago
- Time of India
NO2 levels in city's air three times higher than safe limits
Gurgaon: Concentration of nitrogen dioxide (NO2) -- a pollutant emitted by burning fuel in vehicles, power plants and industries – exceeded the maximum safe limit by three times in the past two days. Data from the Gwal Pahari air quality monitoring station showed that average NO2 for eight hours was 133µg/m³ on Thursday and 123µg/m³ on Friday. In India, the safe limit for exposure to NO2 is 40µg/m³. The maximum concentration considered safe by the World Health Organization is even lower, at 25 µg/m³. Experts said emissions from vehicles, especially in congested areas, is likely to be the key reason for NO2 pollution. They said NO2 does not get as much regulatory attention as other pollutants such as particulate matter (PM2.5 and PM10), though it is associated with exacerbating respiratory ailments. Shubhansh Tiwari, a research associate at the Centre for Science and Environment (CSE), said on Friday, "Elevated NO₂ levels in the city are predominantly due to vehicular emissions. Old vehicles and traffic congestion are key sources of NO2 here." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Asked about action taken to reduce NO2 emissions, an official of the Haryana State Pollution Control Board (HSPCB) said the agency has allowed a private firm to scrap old vehicles. "This aims to remove polluting vehicles from city roads," the official said. A senior HSPCB official said NO2 levels are likely to have spiked after brief relief due to pre-monsoon showers. "The recent rains had kept nitrogen dioxide levels in check by dispersing pollutants. But with clear skies and calmer weather now, NO2 from vehicular and industrial emissions is building up, especially in traffic-dense areas. Unlike particulate matter, NO2 often flies under the radar, but prolonged exposure can be equally hazardous," the official said. Currently, just one of the four air quality monitoring stations is functioning in the city. Dr Bandana Mishra, who heads the pulmonology and respiratory medicine department at Manipal Hospital in Gurgaon said everyone is at risk from high NO2 exposure, but children and the elderly suffer the most. "Nitrogen dioxide exposure can lead to increased inflammation of the airways, which results in persistent cough wheezing, reduced lung function and a higher frequency of asthma attacks," Dr Mishra said. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !